CoChat

Effects of DAU 6215, a novel 5‐hydroxytryptamine3 (5‐HT3) antagonist on electrophysiological properties of the rat hippocampus

Open access
Passani, M.B., Pugliese, A.M., Azzurrini, M., Corradetti, R. · 1994 · British Journal of Pharmacology
Cited by 49

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The aim of the present study was to test the effects of DAU 6215 (endo‐N‐(8‐methyl‐8‐azabicyclo‐[3.2.1]‐octo‐3‐yl)‐2,3‐dihydro‐2‐oxo‐1H‐benzimidazole‐1‐carboxamide hydrochloride), a newly synthesized, selective 5‐hydroxytryptamine 3 (5‐HT 3) antagonist, on the cell membrane properties and on characterized 5‐HT‐mediated responses of pyramidal neurones in the hippocampal CA1 region. Administration of DAU 6215, even at concentrations several hundred fold its Ki, did not affect the cell membrane properties of pyramidal neurones, nor modify extracellularly recorded synaptic potentials, evoked by stimulating the Schaffer's collaterals. Micromolar concentrations (15–30 μ m) of 5‐HT elicited several responses in pyramidal neurones that are mediated by distinct 5‐HT receptor subtypes. DAU 6215 did not antagonize the 5‐HT 1A‐induced membrane hyperpolarization and conductance increase, a response that was blocked by the selective 5‐HT 1A antagonist NAN‐190 (1‐(2‐methoxyphenyl)‐4‐[4‐(2‐phtalamido)butyl‐piperazine). Similarly, DAU 6215 did not affect the membrane depolarization and decrease in amplitude of the afterhyperpolarization, elicited by the activation of putative 5‐HT 4 receptors. 5‐HT increased the frequency of spontaneous postsynaptic potentials (s.p.s.ps) recorded in pyramidal neurones loaded with chloride. In agreement with previous observations, most of the s.p.s.ps were reversed GABAergic events, produced by the activation of 5‐HT 3 receptors on interneurones, because they persisted in the presence of the glutamate NMDA and non NMDA antagonists, d‐aminophosphonovaleric acid (APV; 50 μ m) and 6,7‐dinitroquinoxaline‐2,3‐dione (DNQX; 25 μ m), and were elicited by the selective 5‐HT 3 agonist, 2‐methyl‐5‐HT (2‐Me‐5‐HT, 50 μ m). The increase in frequency of s.p.s.ps induced by 5‐HT was significantly antagonized by DAU 6215 in 70% of the cases, whereas the 5‐HT 3 antagonist always suppressed the effect of 2‐Me‐5‐HT, at concentrations as low as 60 n m. The antagonistic effect of DAU 6215 was also tested on the 5‐HT 3‐mediated block of induction of long‐term potentiation (LTP), elicited by a primed burst (PB) stimulation. Extracellular recordings showed that low concentrations (60 n m) of DAU 6215 suppressed the inhibitory action of 5‐HT on PB‐induced LTP, without affecting the 5‐HT 1A‐induced reduction in the amplitude of the population spike. These results provide evidence that DAU 6215 is an effective antagonist of the 5‐HT 3‐mediated responses in the central nervous system and may offer a cellular correlate for the pharmacological effects of DAU 6215 as an anxiolytic and cognition enhancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.1994.tb13132.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 49

Metadata

Authors
Passani, M. B., Pugliese, A. M., Azzurrini, M., & Corradetti, R.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1994-06
Volume
112
Issue
2
Pages
695-703
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2030587139
Cited by
49
References
2
FWCI
1.75
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of DAU 6215, a novel 5‐hydroxytryptamine3 (5‐HT3) antagonist on electrophysiological properties of the rat hippocampus. https://app.cochat.ai/papers/10.1111/j.1476-5381.1994.tb13132.x
The paper
Passani, M. B., Pugliese, A. M., Azzurrini, M., & Corradetti, R. (1994). Effects of DAU 6215, a novel 5‐hydroxytryptamine3 (5‐HT3) antagonist on electrophysiological properties of the rat hippocampus. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1994.tb13132.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.